EH
UTHR icon

Equitable Holdings’s United Therapeutics UTHR Stock Holding History

Equitable Holdings’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$340K Sell
627
-161
-20% -$90.7K ﹤0.01% 1498
2026
Q1 		$384K Sell
788
-304
-28% -$151K ﹤0.01% 1360
2025
Q4 		$532K Buy
+1,092
New +$509K ﹤0.01% 1086

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Equitable Holdings's UTHR Position: Q2 2026 in Review

Equitable Holdings reduced its United Therapeutics (UTHR) stake by 20% in Q2 2026, selling an estimated $90.7K and leaving 627 shares worth $340K. The position accounts for ﹤0.01% of the portfolio, ranked #1498.

Equitable Holdings first reported a position in UTHR in Q4 2025 and has held it in 3 quarters since. The position peaked at $532K in Q4 2025. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Equitable Holdings held 627 shares of United Therapeutics worth $340K as of Q2 2026.
  • Equitable Holdings sold 161 United Therapeutics shares in Q2 2026, an estimated $90.7K.
  • United Therapeutics made up ﹤0.01% of Equitable Holdings's portfolio in Q2 2026, its #1498 holding.
  • Equitable Holdings first reported a position in United Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Equitable Holdings's United Therapeutics position peaked at $532K in Q4 2025.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Equitable Holdings's 13F filing for Q2 2026, filed 17 Aug 2026.